Related Experiment Video
Updated: May 19, 2026

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro
Published on: January 31, 2022
Glatiramer acetate induced hepatotoxicity.
K Subramaniam1, P Pavli, H Llewellyn
1Gastroenterology and Hepatology Unit, Canberra Hospital, ACT, Australia. kaviths@hotmail.com
Glatiramer acetate, used for multiple sclerosis, can cause severe liver damage. This case highlights the potential for drug toxicity, emphasizing physician awareness for patient safety.
Area of Science:
- Hepatology
- Neurology
- Pharmacology
Background:
- Glatiramer acetate is approved for treating relapsing-remitting multiple sclerosis.
- Multiple sclerosis is a chronic neurological disease affecting the central nervous system.
Related Concept Videos
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Drug toxicity: Idiosyncratic Reactions
Phase II Reactions: Glucuronidation
Bioactivation and Tissue Toxicity
